ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹19,054 Cr | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹19,054 Cr |
| Mar2025 | ₹15,953 Cr |
| Mar2024 | ₹14,060 Cr |
| Mar2023 | ₹12,454 Cr |
| Mar2022 | ₹12,760 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19,054 Cr | 19.44 | |
| Mar2025 | ₹15,953 Cr | 13.46 | |
| Mar2024 | ₹14,060 Cr | 12.89 | |
| Mar2023 | ₹12,454 Cr | -2.40 | |
| Mar2022 | ₹12,760 Cr | - | |
Compare Total Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹63,987.8 Cr | -0.1% | -8% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.1% |
-8% |
-2.1% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses